PL2331128T3 - Kompozycja zawierająca chitozan do doocznego podawania szczepionki (szczepionek) ptakom - Google Patents

Kompozycja zawierająca chitozan do doocznego podawania szczepionki (szczepionek) ptakom

Info

Publication number
PL2331128T3
PL2331128T3 PL09782654T PL09782654T PL2331128T3 PL 2331128 T3 PL2331128 T3 PL 2331128T3 PL 09782654 T PL09782654 T PL 09782654T PL 09782654 T PL09782654 T PL 09782654T PL 2331128 T3 PL2331128 T3 PL 2331128T3
Authority
PL
Poland
Prior art keywords
avians
chitosan
vaccine
composition
ocular administration
Prior art date
Application number
PL09782654T
Other languages
English (en)
Inventor
Yannick Gardin
Vilmos Palya
Sylvain Comte
Original Assignee
Ceva Sante Animale Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale Sa filed Critical Ceva Sante Animale Sa
Publication of PL2331128T3 publication Critical patent/PL2331128T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL09782654T 2008-09-05 2009-09-04 Kompozycja zawierająca chitozan do doocznego podawania szczepionki (szczepionek) ptakom PL2331128T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9464208P 2008-09-05 2008-09-05
US16639809P 2009-04-03 2009-04-03
PCT/EP2009/061508 WO2010026239A1 (en) 2008-09-05 2009-09-04 Composition comprising chitosan for ocular administration of vaccine(s) to avians
EP09782654.9A EP2331128B1 (en) 2008-09-05 2009-09-04 Composition comprising chitosan for ocular administration of vaccine(s) to avians

Publications (1)

Publication Number Publication Date
PL2331128T3 true PL2331128T3 (pl) 2014-06-30

Family

ID=41259493

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09782654T PL2331128T3 (pl) 2008-09-05 2009-09-04 Kompozycja zawierająca chitozan do doocznego podawania szczepionki (szczepionek) ptakom

Country Status (9)

Country Link
US (1) US20110223195A1 (pl)
EP (1) EP2331128B1 (pl)
CN (2) CN103893758A (pl)
BR (1) BRPI0918806B1 (pl)
MX (1) MX2011002441A (pl)
PL (1) PL2331128T3 (pl)
RU (1) RU2498818C2 (pl)
WO (1) WO2010026239A1 (pl)
ZA (1) ZA201101552B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102423304B (zh) * 2011-11-24 2013-03-13 黑龙江大学 N-2-羟丙基三甲基氯化铵壳聚糖/n,o-羧甲基壳聚糖新城疫减毒活疫苗纳米粒的制备方法
CN102973936A (zh) * 2011-12-14 2013-03-20 普莱柯生物工程股份有限公司 壳聚糖在制备禽用疫苗组合物中的应用
EP2644702A1 (en) 2012-03-30 2013-10-02 Ceva Sante Animale Multivalent recombinant avian herpes virus and vaccine for immunizing avian species
CN102824635A (zh) * 2012-08-20 2012-12-19 上海生物制品研究所有限责任公司 壳聚糖作为佐剂在制备流感病毒减毒活疫苗中的应用
AU2014241492A1 (en) 2013-03-12 2015-09-17 Wellstat Vaccines, Llc Antibodies targeted to fungal cell wall polysaccharides
US10709778B2 (en) * 2013-04-24 2020-07-14 Medizinische Universität Wien Vaccine formulation for ocular immunization
WO2015116502A1 (en) * 2014-01-31 2015-08-06 The Regents Of The University Of California Detection and treatment of gnaq mutant uveal melanoma cells with gold nanoparticles
RU2583886C2 (ru) * 2014-02-28 2016-05-10 Пётр Евгеньевич Игнатов Мультипотентная вакцина для профилактики и лечения преимущественно инвазионных и инфекционных болезней, способ применения
CN104857013A (zh) * 2015-03-31 2015-08-26 中国科学院海洋研究所 一种抑制新城疫病毒的药物
CN107446858B (zh) * 2017-09-02 2020-11-03 河南省农业科学院畜牧兽医研究所 一株鸽支原体及其应用
CN114053295A (zh) * 2020-07-29 2022-02-18 以勒企业股份有限公司 几丁聚醣及其衍生物于抗微生物及抗病毒的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5785975A (en) * 1995-06-26 1998-07-28 Research Triangle Pharmaceuticals Adjuvant compositions and vaccine formulations comprising same
DE602004020189D1 (de) * 2003-01-30 2009-05-07 Novartis Vaccines & Diagnostic Adjuvante influenza-vakzine
EP1655021B1 (en) * 2004-11-09 2008-10-29 Novagali Pharma SA Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
WO2007079190A2 (en) * 2005-12-29 2007-07-12 Tti Ellebeau, Inc. Device and method for enhancing immune response by electrical stimulation

Also Published As

Publication number Publication date
EP2331128B1 (en) 2013-11-06
ZA201101552B (en) 2012-05-30
RU2498818C2 (ru) 2013-11-20
WO2010026239A1 (en) 2010-03-11
MX2011002441A (es) 2011-05-19
US20110223195A1 (en) 2011-09-15
BRPI0918806B1 (pt) 2019-02-05
CN103893758A (zh) 2014-07-02
BRPI0918806A2 (pt) 2016-11-01
RU2011112932A (ru) 2012-10-10
EP2331128A1 (en) 2011-06-15
CN102170904A (zh) 2011-08-31

Similar Documents

Publication Publication Date Title
ZA201101552B (en) Composition comprising chitosan for ocular administration of vaccine(s) to avians
PT2482812T (pt) Composições farmacêuticas compreendendo bi-1356 e metformina
PL2512515T3 (pl) Kompozycja farmaceutyczna do leczenia zespołu suchego oka
ZA201100034B (en) Pharmaceutical compositions for treatment of parkinson's disease
ZA201007170B (en) Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
IL216399A0 (en) Pharmaceutical composition for the treatment of heart diseases
EP2414978A4 (en) IMPROVEMENTS IN OR RELATING TO MEDICINE DELIVERY DEVICES
PL2547323T3 (pl) Kompozycja farmaceutyczna do leczenia podwyższonego ciśnienia wewnątrzgałkowego
PL2515941T3 (pl) Preparat farmaceutyczny zawierający bewacyzumab
IL222638A0 (en) Methods and devices for drug delivery to ocular tissue using microneedle
EP2419138A4 (en) GEL COMPOSITIONS FOR THE ADMINISTRATION OF PHARMACEUTICALLY ACTIVE COMPOUNDS
ZA201201712B (en) Novel pharmaceutical formulations against drug misuse
ZA200904756B (en) Methods of vaccine administration
PL2429507T3 (pl) Kompozycja farmaceutyczna wolna od fosforanów do leczenia jaskry
EP2370068A4 (en) METHOD AND COMPOSITIONS FOR DELIVERING MEDICAMENTS TO THE LUNG
IL243204A0 (en) Compositions for vaccination against the dengue virus, and methods for introducing them
EP2542082B8 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-perillyl alcohol
GB0706608D0 (en) Improvements relating to corneal graft preparation
IL213177A0 (en) Crystal forms, methods of preparation, pharmaceutical compositions and uses of nicousamide
EP2498815A4 (en) VACCINE COMPOSITION
GB0815852D0 (en) Improvements relating to pharmaceutical compositions
WO2010006904A3 (en) Crystalline forms of rabeprazole sodium
GB0904700D0 (en) Improvements relating to benefit agent delivery
EP2296687A4 (en) PHARMACEUTICAL COMPOSITIONS OF SOMATOSTATIN DOPAMINE CONJUGATES
PL385972A1 (pl) Kompozycja farmaceutyczna do leczenia chorób przyzębia